Kinetics of Amyloid Aggregation: A Study of the GNNQQNY Prion Sequence
Open Access
- 29 November 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 8 (11) , e1002782
Abstract
The small amyloid-forming GNNQQNY fragment of the prion sequence has been the subject of extensive experimental and numerical studies over the last few years. Using unbiased molecular dynamics with the OPEP coarse-grained potential, we focus here on the onset of aggregation in a 20-mer system. With a total of 16.9 of simulations at 280 K and 300 K, we show that the GNNQQNY aggregation follows the classical nucleation theory (CNT) in that the number of monomers in the aggregate is a very reliable descriptor of aggregation. We find that the critical nucleus size in this finite-size system is between 4 and 5 monomers at 280 K and 5 and 6 at 300 K, in overall agreement with experiment. The kinetics of growth cannot be fully accounted for by the CNT, however. For example, we observe considerable rearrangements after the nucleus is formed, as the system attempts to optimize its organization. We also clearly identify two large families of structures that are selected at the onset of aggregation demonstrating the presence of well-defined polymorphism, a signature of amyloid growth, already in the 20-mer aggregate. Protein aggregation plays an important pathological role in numerous neurodegenerative diseases such as Alzheimer's, Parkinson's, Creutzfeldt-Jakob, the Prion disease and diabetes mellitus. In most cases, misfolded proteins are involved and aggregate irreversibly to form highly ordered insoluble macrostructures, called amyloid fibrils, which deposit in the brain. Studies have revealed that all proteins are capable of forming amyloid fibrils that all share common structural features and therefore aggregation mechanisms. The toxicity of amyloid aggregates is however not attributed to the fibrils themselves but rather to smaller more disordered aggregates, oligomers, forming parallel to or prior to fibrils. Understanding the assembly process of these amyloid oligomers is key to understanding their toxicity mechanism in order to devise a possible treatment strategy targeting these toxic aggregates. Our approach here is to computationally study the aggregation dynamics of a 20-mer of an amyloid peptide GNNQQNY from a prion protein. Our findings suggest that the assembly is a spontaneous process that can be described as a complex nucleation and growth mechanism and which can lead to two classes of morphologies for the aggregates, one of which resembles a protofibril-like structure. Such numerical studies are crucial to understanding the details of fast biological processes and complement well experimental studies.Keywords
This publication has 100 references indexed in Scilit:
- A Variational Model for Oligomer-Formation Process of GNNQQNY Peptide from Yeast Prion Protein Sup35Biophysical Journal, 2012
- Spontaneous Formation of Twisted Aβ16-22 Fibrils in Large-Scale Molecular-Dynamics SimulationsBiophysical Journal, 2011
- Environmental Conditions Affect the Kinetics of Nucleation of Amyloid Fibrils and Determine Their MorphologyBiophysical Journal, 2010
- Structural Characterization of GNNQQNY Amyloid Fibrils by Magic Angle Spinning NMRBiochemistry, 2010
- GNNQQNY—Investigation of Early Steps during Amyloid FormationBiophysical Journal, 2010
- Amyloid Protofibrils of Lysozyme Nucleate and Grow Via Oligomer FusionBiophysical Journal, 2009
- Time‐dependent insulin oligomer reaction pathway prior to fibril formation: Cooling and seedingProteins: Structure, Function, and Bioinformatics, 2009
- Atomic structures of amyloid cross-β spines reveal varied steric zippersNature, 2007
- Structure of the cross-β spine of amyloid-like fibrilsNature, 2005
- Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical featuresBiopolymers, 1983